• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>DRS

DRS

  1. All
  2. 3rd Party
  3. Investing
  1. Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines

    Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines

  2. Cellanyx Diagnostics Announces Expanded Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer

    Cellanyx Diagnostics Announces Expanded Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer

  3. OMT Therapeutics Announces UniRat™ Alliance with Caltech

    OMT Therapeutics Announces UniRatâ„¢ Alliance with Caltech

  4. Data from Recently Published Studies Provide Strong Support for Current and Future Applications of Pressure BioSciences' PCT Platform

    Data from Recently Published Studies Provide Strong Support for Current and Future Applications of Pressure BioSciences' PCT Platform

  5. Roger Ibbotson, Benoit Mandelbrot, and George Cooper

    Our distinguished economics panel debates the value of current risk models.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.